A new device could detect a key endometriosis biomarker in menstrual blood within 10 minutes, researchers have found. The test identifies HMGB1 – a protein linked...
Eight tech startups have joined an accelerator programme developing tools to tackle women’s cardiovascular and brain health conditions. The firms have been selected for the American...
More than 30 MPs have urged the health secretary to act over DES, a pregnancy drug linked to cancer and fertility problems in children exposed in...
Around 5,700 breast cancer patients will now be eligible for ribociclib after NICE widened access to the combination therapy. Ribociclib will be available on the NHS...
Targeted radiotherapy is as effective as full-breast treatment for low-risk breast cancer but causes fewer side effects, a decade-long UK study has found. Partial-breast radiotherapy, which...
Mounjaro may significantly reduce breast cancer tumour growth in obese patients, according to early-stage research in mice. The weight loss drug, which contains tirzepatide, showed what...
Femtech World explores the latest developments in women’s health research – from overcoming EGFR-targeted therapy resistance in breast cancer to understanding obesity’s role in triple-negative breast...
New research suggests that one in three eligible women in the US skip recommended mammograms – leading to late-stage breast cancer diagnosis, doubling treatment costs and...
By Laurent van Lerberghe, managing partner at KELES I often ask myself if technology is the solution to solving complexities in women’s health. Women’s health has...
A pair of experimental drugs slowed tumour growth and blocked resistance mechanisms in ovarian cancer in a new preclinical study. Researchers found the combination selectively targeted...
